Clinical Trial Management System Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Clinical Trial Management System (CTMS) Market to 2025 - Global Analysis and Forecasts By Component (Software and Services), Product (Enterprise Based and Site Based), Delivery Mode (Web Based, Cloud Based and On Premise), End-user (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations [CROs], Medical Device Companies, and Other End Users), and Geography

Report Code: TIPHC00002241 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
A clinical trial management system CTMS is software system to accomplish clinical trial data operations generated by pharmaceutical and biotechnological companies. A CTMS manages up-to-date clinical data initiation from planning of research proposal to preparation, conducting and reporting generation. Clinical trial management system performs planning on budgets, report budgeting, clinical data management and report generation and accordingly the requirements of recipient companies vary from the future prospect.

The increasing research and development activities in the field of health science and clinical research is the foremost factor driving the demand for CTMS. The growing investments from public and private sectors and the introduction of conducive government policies are paving way for increased number of clinical trials, which is expected to boast the Clinical Trial Management System CTMS market during the forecast period.

The "Global Clinical Trial Management System CTMS Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of Global Clinical Trial Management System CTMS market with detailed market segmentation by component, product, delivery mode and end-user. The Global Clinical Trial Management System CTMS market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the Clinical Trial Management System CTMS market.

The Global Clinical Trial Management System CTMS market is segmented on the basis of component, product, delivery mode, and end-user. The component segment includes, software and services. Based on product, the market is segmented as enterprise based and site based. Based on delivery mode, the market is segmented as, web based, cloud based and on premise. Based on end-user, the market is classified as, pharmaceutical & biopharmaceutical companies, clinical research organizations [CROs], medical device companies, and other end users.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Global Clinical Trial Management System CTMS market based on component, product, delivery mode and end-user. It also provides market size and forecast till 2025 for overall Clinical Trial Management System CTMS market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Clinical Trial Management System CTMS market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to dominate this market in the forecast period due to favorable government initiatives, and support from government bodies. Also the raising awareness among people regarding diseases is expected to increase their participation in clinical trials. The Clinical Trial Management System CTMS market in Asia-Pacific is anticipated to grow during the forecast period owing to factors, such as huge, diverse patient pool, outsourcing of clinical trials to CROs, and rising healthcare facilities in the region.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Clinical Trial Management System CTMS market in these regions.
The report also includes the profiles of key Clinical Trial Management System CTMS providers along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the Clinical Trial Management System CTMS market are Oracle, Medidata Solutions Inc., PAREXEL International Corporation., MedNet Solutions, Inc., Bioclinica, BioOptronics, Inc., DATATRAK Int., ERT Clinical, FORTE, and ICON plc among others.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Clinical Trial Management System (CTMS) Market - By Component
3.2.2. Clinical Trial Management System (CTMS) Market - By Product
3.2.3. Clinical Trial Management System (CTMS) Market - By Delivery Mode
3.2.4. Clinical Trial Management System (CTMS) Market - By End User
3.2.5. Clinical Trial Management System (CTMS) Market - By Region
3.2.5.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET - GLOBAL ANALYSIS
5.1. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET OVERVIEW
5.2. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

6. CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS TO 2025 - BY COMPONENT
6.1. OVERVIEW
6.2. CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY COMPONENT (US$ MN)
6.3. SOFTWARE MARKET
6.3.1. Overview
6.3.2. Software Market Revenue Forecasts and Analysis (US$ Mn)
6.4. SERVICES MARKET
6.4.1. Overview
6.4.2. Services Market Revenue Forecasts and Analysis (US$ Mn)

7. CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT
7.1. OVERVIEW
7.2. CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
7.3. ENTERPRISE BASED MARKET
7.3.1. Overview
7.3.2. Enterprise Based Market Revenue Forecasts and Analysis (US$ Mn)
?
7.4. SITE BASED MARKET
7.4.1. Overview
7.4.2. Site Based Market Revenue Forecasts and Analysis (US$ Mn)

8. CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS TO 2025 - BY DELIVERY MODE
8.1. OVERVIEW
8.2. CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY DELIVERY MODE (US$ MN)
8.3. WEB-BASED MARKET
8.3.1. Overview
8.3.2. Web-based Market Revenue Forecasts and Analysis (US$ Mn)
8.4. CLOUD-BASED MARKET
8.4.1. Overview
8.4.2. Cloud-based Market Revenue Forecasts and Analysis (US$ Mn)
8.5. ON PREMISE MARKET
8.5.1. Overview
8.5.2. On premise Market Revenue Forecasts and Analysis (US$ Mn)

9. CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
9.1. OVERVIEW
9.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET
9.3.1. Overview
9.3.2. Pharmaceutical & Biopharmaceutical Companies Market Revenue Forecasts and Analysis (US$ Mn)
9.4. CLINICAL RESEARCH ORGANIZATIONS [CROS] MARKET
9.4.1. Overview
9.4.2. Clinical Research Organizations [CROs] Market Revenue Forecasts and Analysis (US$ Mn)
?
9.5. MEDICAL DEVICE COMPANIES MARKET
9.5.1. Overview
9.5.2. Medical Device Companies Market Revenue Forecasts and Analysis (US$ Mn)
9.6. OTHER END USERS MARKET
9.6.1. Overview
9.6.2. Other End Users Market Revenue Forecasts and Analysis (US$ Mn)

10. NORTH AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. NORTH AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET OVERVIEW
10.2. NORTH AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. NORTH AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY COMPONENT (US$ MN)
10.4. NORTH AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.5. NORTH AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY DELIVERY MODE (US$ MN)
10.6. NORTH AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.7. NORTH AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
10.8. US MARKET OVERVIEW
10.8.1. US Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
10.8.2. US Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.3. US Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
10.8.4. US Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. CANADA MARKET OVERVIEW
10.9.1. Canada Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
10.9.2. Canada Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.9.3. Canada Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
10.9.4. Canada Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.10. MEXICO MARKET OVERVIEW
10.10.1. Mexico Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
10.10.2. Mexico Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.10.3. Mexico Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
10.10.4. Mexico Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. EUROPE CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. EUROPE CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET OVERVIEW
11.2. EUROPE CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. EUROPE CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY COMPONENT (US$ MN)
11.4. EUROPE CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY DELIVERY MODE (US$ MN)
11.5. EUROPE CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.6. EUROPE CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.7. EUROPE CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
11.8. FRANCE MARKET OVERVIEW
11.8.1. France Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
11.8.2. France Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.3. France Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
11.8.4. France Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. GERMANY MARKET OVERVIEW
11.9.1. Germany Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
11.9.2. Germany Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.9.3. Germany Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
11.9.4. Germany Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.10. UK MARKET OVERVIEW
11.10.1. UK Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
11.10.2. UK Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.10.3. UK Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
11.10.4. UK Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. ASIA PACIFIC CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. ASIA PACIFIC CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET OVERVIEW
12.2. ASIA PACIFIC CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. ASIA PACIFIC CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY COMPONENT (US$ MN)
12.4. ASIA PACIFIC CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.5. ASIA PACIFIC CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY DELIVERY MODE (US$ MN)
12.6. ASIA PACIFIC CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.7. ASIA PACIFIC CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
12.8. CHINA MARKET OVERVIEW
12.8.1. China Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
12.8.2. China Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.8.3. China Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
12.8.4. China Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. INDIA MARKET OVERVIEW
12.9.1. India Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
12.9.2. India Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.9.3. India Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
12.9.4. India Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.10. JAPAN MARKET OVERVIEW
12.10.1. Japan Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
12.10.2. Japan Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.10.3. Japan Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
12.10.4. Japan Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. MIDDLE EAST AND AFRICA (MEA) CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. MIDDLE EAST AND AFRICA (MEA) CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET OVERVIEW
13.2. MIDDLE EAST AND AFRICA (MEA) CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. MIDDLE EAST AND AFRICA (MEA) CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY COMPONENT (US$ MN)
13.4. MIDDLE EAST AND AFRICA (MEA) CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.5. MIDDLE EAST AND AFRICA (MEA) CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY DELIVERY MODE (US$ MN)
13.6. MIDDLE EAST AND AFRICA (MEA) CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.7. MIDDLE EAST AND AFRICA (MEA) CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
13.8. SOUTH AFRICA MARKET OVERVIEW
13.8.1. South Africa Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
13.8.2. South Africa Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.8.3. South Africa Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
13.8.4. South Africa Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.9. SAUDI ARABIA MARKET OVERVIEW
13.9.1. Saudi Arabia Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
13.9.2. Saudi Arabia Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.9.3. Saudi Arabia Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
13.9.4. Saudi Arabia Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.10. UAE MARKET OVERVIEW
13.10.1. UAE Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
13.10.2. UAE Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.10.3. UAE Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
13.10.4. UAE Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. SOUTH AND CENTRAL AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
14.1. SOUTH AND CENTRAL AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET OVERVIEW
14.2. SOUTH AND CENTRAL AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. SOUTH AND CENTRAL AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY COMPONENT (US$ MN)
14.4. SOUTH AND CENTRAL AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
14.5. SOUTH AND CENTRAL AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY DELIVERY MODE (US$ MN)
14.6. SOUTH AND CENTRAL AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
14.7. SOUTH AND CENTRAL AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
14.8. BRAZIL MARKET OVERVIEW
14.8.1. Brazil Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Component (US$ Mn)
14.8.2. Brazil Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
14.8.3. Brazil Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By Delivery Mode (US$ Mn)
14.8.4. Brazil Clinical Trial Management System (CTMS) Market Revenue Forecasts and Analysis - By End User (US$ Mn)

15. CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET, KEY COMPANY PROFILES
15.1. ORACLE
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product/Service Portfolio
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. MEDIDATA SOLUTIONS INC.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product/Service Portfolio
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. PAREXEL INTERNATIONAL CORPORATION
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product/Service Portfolio
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. MEDNET SOLUTIONS, INC.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product/Service Portfolio
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. BIOCLINICA
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product/Service Portfolio
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. BIO-OPTRONICS, INC.
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product/Service Portfolio
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. DATATRAK INT.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product/Service Portfolio
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. ERT CLINICAL
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product/Service Portfolio
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. FORTE
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product/Service Portfolio
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. ICON PLC
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product/Service Portfolio
15.10.5. SWOT Analysis
15.10.6. Key Developments

16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY

The List of Companies

1. Oracle
2. Medidata Solutions Inc.
3. PAREXEL International Corporation.
4. MedNet Solutions, Inc.
5. Bioclinica
6. BioOptronics, Inc.
7. DATATRAK Int.
8. ERT Clinical
9. FORTE
10. ICON plc

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book